[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-001", "question": "A 68-year-old man with a history of severe aortic stenosis (mean gradient 48 mmHg, AVA 0.7 cm²) presents with decompensated heart failure. He is hypotensive (85/50 mmHg) and hypoxic despite high-flow oxygen. Transthoracic echocardiography shows a hyperdynamic left ventricle with near-cavity obliteration, severe mitral regurgitation (new, eccentric posteriorly directed jet), and systolic anterior motion of the mitral valve with LVOT obstruction (peak gradient 120 mmHg). Which of the following is the single most appropriate immediate pharmacologic intervention?", "options": ["Intravenous phenylephrine infusion", "Intravenous esmolol infusion", "Intravenous nitroglycerin infusion", "Intravenous furosemide bolus", "Intravenous milrinone infusion"], "answer": "A", "answer_index": 0, "explanation": "This patient has severe aortic stenosis with a dynamic LVOT obstruction (systolic anterior motion) precipitated by hypovolemia and hypercontractility, leading to hypotension and secondary mitral regurgitation. Phenylephrine, an alpha-agonist, increases afterload and blood pressure, which reduces the LVOT gradient and improves forward flow. Esmolol (negative inotrope) could worsen heart failure in the setting of severe AS. Nitroglycerin and furosemide reduce preload, exacerbating the obstruction. Milrinone is a positive inotrope and vasodilator, which would dramatically worsen the LVOT gradient and hypotension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the immediate pharmacologic intervention for a patient with severe aortic stenosis complicated by dynamic LVOT obstruction due to systolic anterior motion (SAM) of the mitral valve, leading to hypotension, hypoxia, and severe mitral regurgitation in decompensated heart failure. Key stem clues driving a unique best answer include severe AS (mean gradient 48 mmHg, AVA 0.7 cm²), hypotension (85/50 mmHg), hyperdynamic LV with near-cavity obliteration, new eccentric posteriorly directed severe MR jet, SAM with LVOT obstruction (peak gradient 120 mmHg), and hypoxia despite high-flow oxygen. These indicate a HOCM-like physiology with dynamic obstruction exacerbated by hypovolemia and hypercontractility. The most likely mechanism is Venturi effect causing SAM and secondary MR. Keyed answer A (IV phenylephrine) fits by increasing afterload to reduce LVOT gradient and improve forward flow, assuming no contraindications like severe hypertension. Alternatives: B (esmolol) worsens heart failure in severe AS by negative inotropy; C (nitroglycerin) reduces preload/afterload, exacerbating obstruction; D (furosemide) decreases preload, worsening hypovolemia and gradient; E (milrinone) increases inotropy and vasodilation, aggravating obstruction and hypotension. No main logical issues; stem is consistent and specifies a unique best answer. No main medical accuracy issues; aligns with guidelines for managing dynamic LVOT obstruction in AS, similar to HOCM management (e.g., alpha-agonists preferred). Minimal fix: None needed; item is unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the immediate pharmacologic intervention for a patient with severe aortic stenosis complicated by dynamic LVOT obstruction due to systolic anterior motion (SAM) of the mitral valve, leading to hypotension, hypoxia, and severe mitral regurgitation in decompensated heart failure. Key stem clues driving a unique best answer include severe AS (mean gradient 48 mmHg, AVA 0.7 cm²), hypotension (85/50 mmHg), hyperdynamic LV with near-cavity obliteration, new eccentric posteriorly directed severe MR jet, SAM with LVOT obstruction (peak gradient 120 mmHg), and hypoxia despite high-flow oxygen. These indicate a HOCM-like physiology with dynamic obstruction exacerbated by hypovolemia and hypercontractility. The most likely mechanism is Venturi effect causing SAM and secondary MR. Keyed answer A (IV phenylephrine) fits by increasing afterload to reduce LVOT gradient and improve forward flow, assuming no contraindications like severe hypertension. Alternatives: B (esmolol) worsens heart failure in severe AS by negative inotropy; C (nitroglycerin) reduces preload/afterload, exacerbating obstruction; D (furosemide) decreases preload, worsening hypovolemia and gradient; E (milrinone) increases inotropy and vasodilation, aggravating obstruction and hypotension. No main logical issues; stem is consistent and specifies a unique best answer. No main medical accuracy issues; aligns with guidelines for managing dynamic LVOT obstruction in AS, similar to HOCM management (e.g., alpha-agonists preferred). Minimal fix: None needed; item is unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-002", "question": "A 3-day-old full-term neonate, born via uncomplicated vaginal delivery, is noted to have progressive tachypnea, grunting, and hypoxemia requiring 60% FiO2. Chest X-ray shows diffuse granular opacities with air bronchograms. Surfactant administration provides minimal improvement. Echocardiogram shows normal cardiac anatomy, but there is severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale. Which of the following underlying conditions is the most likely cause of this refractory pulmonary hypertension of the newborn?", "options": ["Congenital alveolar capillary dysplasia", "Meconium aspiration syndrome", "Transient tachypnea of the newborn", "Group B streptococcal pneumonia", "Idiopathic respiratory distress syndrome"], "answer": "A", "answer_index": 0, "explanation": "Congenital alveolar capillary dysplasia (ACD) with misalignment of pulmonary veins is a rare, lethal lung developmental disorder that presents identically to severe persistent pulmonary hypertension of the newborn (PPHN) but is completely refractory to all standard therapies, including surfactant, inhaled nitric oxide, and ECMO. The history of a full-term infant with rapid progression and lack of response to surfactant is classic. Meconium aspiration and sepsis can cause severe PPHN but typically show some response to aggressive management. Transient tachypnea and idiopathic RDS are not associated with such severe, immediate refractory pulmonary hypertension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include: full-term neonate with progressive tachypnea, grunting, hypoxemia requiring 60% FiO2; CXR showing diffuse granular opacities with air bronchograms; minimal improvement with surfactant; echocardiogram revealing normal anatomy but severe pulmonary hypertension with suprasystemic RV pressures and right-to-left shunting via PFO. These findings point to a rare developmental disorder causing refractory PPHN, distinguishing it from more common etiologies. Main logical issue(s): none; the stem provides sufficient discriminating details (e.g., full-term status, CXR pattern, lack of surfactant response, severe refractory PPHN) to support a single best answer without contradictions or underspecification. Alternatives are inferior: B (meconium aspiration) and D (GBS pneumonia) can cause PPHN but typically respond better to management; C (TTN) is mild and self-resolving without severe PPHN; E (IRDS) is primarily preterm and surfactant-responsive. Main medical accuracy issue(s): none; the item aligns with current understanding of congenital alveolar capillary dysplasia (ACD) as a cause of lethal, refractory PPHN in term infants, consistent with pediatric pulmonology guidelines and board-level knowledge. Minimal fix: none required, as the item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include: full-term neonate with progressive tachypnea, grunting, hypoxemia requiring 60% FiO2; CXR showing diffuse granular opacities with air bronchograms; minimal improvement with surfactant; echocardiogram revealing normal anatomy but severe pulmonary hypertension with suprasystemic RV pressures and right-to-left shunting via PFO. These findings point to a rare developmental disorder causing refractory PPHN, distinguishing it from more common etiologies. Main logical issue(s): none; the stem provides sufficient discriminating details (e.g., full-term status, CXR pattern, lack of surfactant response, severe refractory PPHN) to support a single best answer without contradictions or underspecification. Alternatives are inferior: B (meconium aspiration) and D (GBS pneumonia) can cause PPHN but typically respond better to management; C (TTN) is mild and self-resolving without severe PPHN; E (IRDS) is primarily preterm and surfactant-responsive. Main medical accuracy issue(s): none; the item aligns with current understanding of congenital alveolar capillary dysplasia (ACD) as a cause of lethal, refractory PPHN in term infants, consistent with pediatric pulmonology guidelines and board-level knowledge. Minimal fix: none required, as the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-003", "question": "A 42-year-old woman is brought to the ED after a high-speed motor vehicle collision. Primary survey reveals a Glasgow Coma Scale of 14, heart rate 130 bpm, BP 88/50 mmHg, and SpO2 94% on room air. Focused Assessment with Sonography for Trauma (FAST) is positive for fluid in the hepatorenal recess. After initiating a massive transfusion protocol, her blood pressure transiently improves with crystalloid, then drops again. Bedside ultrasound now shows a new, large pericardial effusion with diastolic right ventricular collapse. Which of the following is the most appropriate immediate procedural intervention?", "options": ["Emergency department thoracotomy", "Pericardiocentesis via subxiphoid approach", "Left anterolateral tube thoracostomy", "Right tube thoracostomy", "Laparotomy with aortic cross-clamping"], "answer": "B", "answer_index": 1, "explanation": "The patient has developed cardiac tamponade (evidenced by diastolic RV collapse on ultrasound) in the context of trauma and a positive FAST exam, suggesting concurrent intra-abdominal hemorrhage. In blunt trauma, the cause is likely myocardial rupture or coronary vessel injury. Pericardiocentesis is the immediate life-saving procedure to relieve tamponade while simultaneously preparing for definitive operative management. ED thoracotomy is indicated for penetrating trauma with recent loss of signs of life. Tube thoracostomy addresses hemothorax, not pericardial tamponade. Laparotomy addresses the abdominal hemorrhage but would not relieve the cardiac tamponade, and the patient would likely arrest on induction of anesthesia.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include blunt trauma from high-speed MVC, initial hypotension and tachycardia, positive FAST in hepatorenal recess indicating abdominal hemorrhage, transient BP improvement with fluids and transfusion followed by drop, and new ultrasound showing large pericardial effusion with diastolic RV collapse, diagnostic of cardiac tamponade. These clues point to immediate need for tamponade relief amid ongoing hemorrhage. Main logical issue(s): None; the stem provides sufficient details to discriminate B as the single best immediate intervention without contradictions or underspecification. Alternatives are inferior: A is for penetrating trauma with arrest; C and D address potential hemothorax, not tamponade; E targets abdominal bleeding but ignores acute tamponade, risking arrest. Main medical accuracy issue(s): None; aligns with ATLS guidelines for pericardiocentesis in unstable traumatic tamponade to stabilize before definitive surgery, reflecting current standards without inaccuracies or outdated elements. Minimal fix: None required; item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include blunt trauma from high-speed MVC, initial hypotension and tachycardia, positive FAST in hepatorenal recess indicating abdominal hemorrhage, transient BP improvement with fluids and transfusion followed by drop, and new ultrasound showing large pericardial effusion with diastolic RV collapse, diagnostic of cardiac tamponade. These clues point to immediate need for tamponade relief amid ongoing hemorrhage. Main logical issue(s): None; the stem provides sufficient details to discriminate B as the single best immediate intervention without contradictions or underspecification. Alternatives are inferior: A is for penetrating trauma with arrest; C and D address potential hemothorax, not tamponade; E targets abdominal bleeding but ignores acute tamponade, risking arrest. Main medical accuracy issue(s): None; aligns with ATLS guidelines for pericardiocentesis in unstable traumatic tamponade to stabilize before definitive surgery, reflecting current standards without inaccuracies or outdated elements. Minimal fix: None required; item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-004", "question": "A 28-year-old woman presents with a 6-month history of symmetric inflammatory polyarthritis affecting her wrists, MCPs, and knees, morning stiffness >1 hour, and a new facial rash. Labs show ANA 1:1280 (speckled), anti-dsDNA negative, anti-Smith positive, anti-RNP positive, complement levels normal, and urinalysis with 2+ protein but no cellular casts. She is started on hydroxychloroquine. Two weeks later, she develops acute dyspnea, pleuritic chest pain, and hypoxia. CT pulmonary angiography shows no pulmonary embolism but reveals extensive bilateral ground-glass opacities and pleural effusions. Which of the following is the most likely diagnosis?", "options": ["Lupus pneumonitis", "Drug reaction to hydroxychloroquine", "Acute pulmonary hemorrhage from vasculitis", "Pulmonary hypertension due to SLE", "Opportunistic infection due to immunosuppression"], "answer": "A", "answer_index": 0, "explanation": "The patient has SLE (meeting criteria with arthritis, malar rash, anti-Smith positivity). The acute respiratory presentation with ground-glass opacities and pleural effusions in this context is most consistent with acute lupus pneumonitis, a rare but severe manifestation of SLE. Timing makes drug reaction unlikely, as hydroxychloroquine toxicity is typically chronic and not acute pulmonary. Pulmonary hemorrhage would show falling hematocrit and more alveolar filling. Pulmonary hypertension is a chronic process. Opportunistic infection is improbable given the very short course of a minimally immunosuppressive agent (hydroxychloroquine).", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the most likely cause of acute dyspnea, pleuritic chest pain, and hypoxia with bilateral ground-glass opacities and pleural effusions on CT in a 28-year-old woman with newly diagnosed SLE, two weeks after starting hydroxychloroquine. Key stem clues driving unique best answer: symmetric inflammatory polyarthritis, morning stiffness >1 hour, facial rash, ANA 1:1280 speckled, anti-Smith positive, anti-RNP positive, normal complements, proteinuria without casts (confirming SLE); acute respiratory symptoms post-HCQ initiation, CT showing GGO and effusions without PE. Most likely diagnosis: acute lupus pneumonitis, a severe SLE manifestation. Keyed answer A fits: aligns with acute inflammatory lung involvement in active SLE, supported by timing and imaging. Alternatives: B worse due to atypical acute timing for HCQ pneumonitis (usually chronic); C incorrect without hemoptysis, anemia, or alveolar filling; D mismatched as pulmonary hypertension is chronic; E unlikely with minimal immunosuppression and short duration. No main logical issues: stem allows unique best answer without contradictions or underspecification. No main medical accuracy issues: consistent with ACR/EULAR SLE criteria, standard recognition of lupus pneumonitis (rare but acute with GGO/effusions), and guideline-based HCQ use. Minimal fix: No edit required; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the most likely cause of acute dyspnea, pleuritic chest pain, and hypoxia with bilateral ground-glass opacities and pleural effusions on CT in a 28-year-old woman with newly diagnosed SLE, two weeks after starting hydroxychloroquine. Key stem clues driving unique best answer: symmetric inflammatory polyarthritis, morning stiffness >1 hour, facial rash, ANA 1:1280 speckled, anti-Smith positive, anti-RNP positive, normal complements, proteinuria without casts (confirming SLE); acute respiratory symptoms post-HCQ initiation, CT showing GGO and effusions without PE. Most likely diagnosis: acute lupus pneumonitis, a severe SLE manifestation. Keyed answer A fits: aligns with acute inflammatory lung involvement in active SLE, supported by timing and imaging. Alternatives: B worse due to atypical acute timing for HCQ pneumonitis (usually chronic); C incorrect without hemoptysis, anemia, or alveolar filling; D mismatched as pulmonary hypertension is chronic; E unlikely with minimal immunosuppression and short duration. No main logical issues: stem allows unique best answer without contradictions or underspecification. No main medical accuracy issues: consistent with ACR/EULAR SLE criteria, standard recognition of lupus pneumonitis (rare but acute with GGO/effusions), and guideline-based HCQ use. Minimal fix: No edit required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-005", "question": "A 55-year-old man with a history of MEN1 syndrome (previous parathyroidectomy, pancreatic neuroendocrine tumor resection) presents with profound hypoglycemia (glucose 38 mg/dL) and inappropriately elevated serum insulin and C-peptide during a supervised fast. Localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, show no identifiable pancreatic lesion. Which of the following is the most appropriate next step in management?", "options": ["Empiric distal pancreatectomy", "Initiation of diazoxide therapy", "Selective arterial calcium stimulation with hepatic venous sampling", "Empiric total pancreatectomy", "Long-acting somatostatin analog therapy (e.g., lanreotide)"], "answer": "C", "answer_index": 2, "explanation": "In a patient with MEN1 and biochemically proven endogenous hyperinsulinemic hypoglycemia (insulinoma) with negative conventional and advanced imaging, the next step is selective arterial calcium stimulation (SACS) with hepatic venous sampling. This invasive angiographic procedure can regionalize the source of insulin secretion to a specific pancreatic arterial territory (gastroduodenal, superior mesenteric, or splenic arteries), guiding targeted surgical exploration. Empiric distal or total pancreatectomy carries high morbidity and may miss the lesion. Diazoxide and somatostatin analogs are temporizing medical therapies but do not address the need for definitive localization and resection in a surgical candidate.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 55-year-old with MEN1 history (parathyroidectomy, pancreatic NET resection), profound hypoglycemia (38 mg/dL) with elevated insulin/C-peptide during fast, negative localizing studies (EUS, Ga-68 DOTATATE PET/CT). These indicate endogenous hyperinsulinism likely due to occult insulinoma in MEN1 context, requiring precise localization for surgery. Main logical issue(s): None; stem provides sufficient details for discriminating C as best next step for regionalization via SACS, while alternatives are either high-risk empiric surgeries (A, D) or non-definitive medical options (B, E). Main medical accuracy issue(s): None; aligns with current guidelines (e.g., ENETS, NANETS) for insulinoma management in MEN1, where negative imaging prompts invasive localization like SACS before targeted resection, avoiding blind pancreatectomy due to morbidity. The item's logic correctly prioritizes definitive surgical planning over temporizing measures in a surgical candidate. Minimal fix: Not needed; item is already unambiguous and accurate. Best-answer defensibility: The question asks for the most appropriate next management step in biochemically confirmed insulinoma with negative imaging. Discriminating findings: Positive - MEN1 predisposition to multifocal NETs, confirmed hyperinsulinemic hypoglycemia; Negative - no lesion on advanced imaging. Implied: Occult insulinoma needing localization. Keyed C fits as it guides targeted surgery without unnecessary resection. Alternatives: A/D worse due to high morbidity without localization; B/E are medical bridges, not next for definitive cure.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 55-year-old with MEN1 history (parathyroidectomy, pancreatic NET resection), profound hypoglycemia (38 mg/dL) with elevated insulin/C-peptide during fast, negative localizing studies (EUS, Ga-68 DOTATATE PET/CT). These indicate endogenous hyperinsulinism likely due to occult insulinoma in MEN1 context, requiring precise localization for surgery. Main logical issue(s): None; stem provides sufficient details for discriminating C as best next step for regionalization via SACS, while alternatives are either high-risk empiric surgeries (A, D) or non-definitive medical options (B, E). Main medical accuracy issue(s): None; aligns with current guidelines (e.g., ENETS, NANETS) for insulinoma management in MEN1, where negative imaging prompts invasive localization like SACS before targeted resection, avoiding blind pancreatectomy due to morbidity. The item's logic correctly prioritizes definitive surgical planning over temporizing measures in a surgical candidate. Minimal fix: Not needed; item is already unambiguous and accurate. Best-answer defensibility: The question asks for the most appropriate next management step in biochemically confirmed insulinoma with negative imaging. Discriminating findings: Positive - MEN1 predisposition to multifocal NETs, confirmed hyperinsulinemic hypoglycemia; Negative - no lesion on advanced imaging. Implied: Occult insulinoma needing localization. Keyed C fits as it guides targeted surgery without unnecessary resection. Alternatives: A/D worse due to high morbidity without localization; B/E are medical bridges, not next for definitive cure.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-006", "question": "A 7-year-old boy is evaluated for short stature. He has a history of congenital hypothyroidism diagnosed on newborn screening, treated with levothyroxine. Growth chart shows length and weight at the 5th percentile at birth, falling to below the 1st percentile by age 3. Current bone age is delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly. Labs show normal TSH and free T4 on replacement. Which of the following genetic mutations is most likely responsible for this clinical picture?", "options": ["SHOX gene mutation", "GH1 gene mutation (isolated GH deficiency)", "GNAS1 gene mutation (Albright hereditary osteodystrophy)", "PROP1 gene mutation (combined pituitary hormone deficiency)", "FGFR3 gene mutation (achondroplasia)"], "answer": "D", "answer_index": 3, "explanation": "The combination of congenital hypothyroidism, severe postnatal growth failure with delayed bone age, and mild facial dysmorphism is classic for combined pituitary hormone deficiency (CPHD) due to a PROP1 mutation. PROP1 is a pituitary transcription factor critical for the development of somatotrophs, lactotrophs, thyrotrophs, and gonadotrophs. Deficiency presents with growth hormone, TSH, and later gonadotropin deficiencies. The congenital hypothyroidism was central (pituitary), not primary thyroidal. SHOX mutations cause Leri-Weill dyschondrosteosis. GNAS1 mutations cause pseudohypoparathyroidism with specific skeletal findings (brachydactyly type E). Isolated GH deficiency or achondroplasia would not explain the central hypothyroidism.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed; unique best is C, not D. The clinical problem asks for the genetic mutation most likely causing short stature with congenital hypothyroidism detected on newborn screening, postnatal growth failure, delayed bone age, and dysmorphic features (prominent forehead, depressed nasal bridge, brachydactyly) in a 7-year-old boy. Key stem clues: NBS-diagnosed hypothyroidism treated to normal TSH and free T4; birth size at 5th percentile falling below 1st by age 3; 3-year bone age delay; facial and hand dysmorphism. These imply pseudohypoparathyroidism type 1a/Albright hereditary osteodystrophy (AHO) due to GNAS mutation, featuring TSH resistance (hypothyroidism with high TSH at diagnosis, normalizes on levothyroxine), short stature, delayed bone age, and classic brachydactyly/facial findings. Keyed answer D (PROP1) evaluation: Inconsistent with normal TSH on replacement (should be low in central hypothyroidism) and atypical brachydactyly for PROP1-related combined pituitary hormone deficiency. Alternatives: A (SHOX) lacks hypothyroidism/dysmorphism; B (GH1) no hypothyroidism; C (GNAS1) best fit as above; E (FGFR3) disproportionate stature, no hypothyroidism, mismatched features. Main logical issue: Stem supports unique best (C) without contradictions, but key mismatches it. Main medical accuracy issues: Inaccurate portrayal of PROP1 causing brachydactyly (not typical) and normal TSH in treated central hypothyroidism (TSH remains low); GNAS better aligns with guidelines for AHO/PHP1a, including NBS detection via elevated TSH. Minimal fix: Change keyed answer to C.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed; unique best is C, not D. The clinical problem asks for the genetic mutation most likely causing short stature with congenital hypothyroidism detected on newborn screening, postnatal growth failure, delayed bone age, and dysmorphic features (prominent forehead, depressed nasal bridge, brachydactyly) in a 7-year-old boy. Key stem clues: NBS-diagnosed hypothyroidism treated to normal TSH and free T4; birth size at 5th percentile falling below 1st by age 3; 3-year bone age delay; facial and hand dysmorphism. These imply pseudohypoparathyroidism type 1a/Albright hereditary osteodystrophy (AHO) due to GNAS mutation, featuring TSH resistance (hypothyroidism with high TSH at diagnosis, normalizes on levothyroxine), short stature, delayed bone age, and classic brachydactyly/facial findings. Keyed answer D (PROP1) evaluation: Inconsistent with normal TSH on replacement (should be low in central hypothyroidism) and atypical brachydactyly for PROP1-related combined pituitary hormone deficiency. Alternatives: A (SHOX) lacks hypothyroidism/dysmorphism; B (GH1) no hypothyroidism; C (GNAS1) best fit as above; E (FGFR3) disproportionate stature, no hypothyroidism, mismatched features. Main logical issue: Stem supports unique best (C) without contradictions, but key mismatches it. Main medical accuracy issues: Inaccurate portrayal of PROP1 causing brachydactyly (not typical) and normal TSH in treated central hypothyroidism (TSH remains low); GNAS better aligns with guidelines for AHO/PHP1a, including NBS detection via elevated TSH. Minimal fix: Change keyed answer to C.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-007", "question": "A 70-year-old man with severe, calcific aortic stenosis (AVA 0.6 cm², mean gradient 55 mmHg) and chronic kidney disease (eGFR 28 mL/min/1.73m²) presents with recurrent hospitalizations for heart failure with preserved ejection fraction (LVEF 65%). He is deemed high-risk for surgical AVR. He undergoes transcatheter aortic valve implantation (TAVI) with a balloon-expandable valve. Immediately post-deployment, transesophageal echocardiography shows a well-seated valve with mild paravalvular leak, mean gradient 8 mmHg, and new severe mitral regurgitation with a wide vena contracta and eccentric anteriorly directed jet. The left ventricular systolic function appears hyperdynamic. What is the most likely mechanism of the acute severe mitral regurgitation?", "options": ["Iatrogenic injury to the mitral valve apparatus from the delivery system", "Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve", "Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction", "Valve prosthesis impingement on the anterior mitral leaflet", "Acute papillary muscle dysfunction due to coronary occlusion"], "answer": "B", "answer_index": 1, "explanation": "In a patient with severe AS and a small, hypertrophied, hyperdynamic left ventricle, relief of the afterload obstruction via TAVI can precipitate dynamic LVOT obstruction. This leads to systolic anterior motion (SAM) of the mitral valve, causing acute, severe mitral regurgitation with an eccentric anterior jet. This is a recognized complication of TAVI, particularly in patients with certain anatomical predictors (septal hypertrophy, small LV cavity). Direct injury from the delivery system is rare. Pre-existing severe MR would have been evident pre-procedure. Prosthetic impingement typically causes central MR. Coronary occlusion is possible but would more likely cause regional wall motion abnormalities and ischemic MR.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include severe calcific AS with small AVA and high gradient, HFpEF with preserved LVEF (65%), hyperdynamic LV post-TAVI, new severe MR with wide vena contracta and eccentric anteriorly directed jet, well-seated valve with low post-gradient (8 mmHg), and mild paravalvular leak. These suggest relief of afterload unmasking dynamic LVOT obstruction in a likely hypertrophied, small LV, leading to SAM and eccentric MR. No clues for direct injury (A, rare and unsupported), pre-existing ischemic MR (C, would be evident pre-procedure, no ischemia mentioned), prosthetic impingement (D, typically central MR), or coronary occlusion (E, no wall motion abnormalities). Main logical issue(s): none; stem provides sufficient discriminating details for unique best answer without contradictions or underspecification. Main medical accuracy issue(s): none; aligns with recognized TAVI complication of SAM in patients with septal hypertrophy and small LV cavities, per current guidelines (e.g., ACC/AHA). Mechanism is precise and board-relevant. Minimal fix: none required, as item is unambiguous and accurate; optionally, explicitly state LV hypertrophy in stem for added clarity without changing intent.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include severe calcific AS with small AVA and high gradient, HFpEF with preserved LVEF (65%), hyperdynamic LV post-TAVI, new severe MR with wide vena contracta and eccentric anteriorly directed jet, well-seated valve with low post-gradient (8 mmHg), and mild paravalvular leak. These suggest relief of afterload unmasking dynamic LVOT obstruction in a likely hypertrophied, small LV, leading to SAM and eccentric MR. No clues for direct injury (A, rare and unsupported), pre-existing ischemic MR (C, would be evident pre-procedure, no ischemia mentioned), prosthetic impingement (D, typically central MR), or coronary occlusion (E, no wall motion abnormalities). Main logical issue(s): none; stem provides sufficient discriminating details for unique best answer without contradictions or underspecification. Main medical accuracy issue(s): none; aligns with recognized TAVI complication of SAM in patients with septal hypertrophy and small LV cavities, per current guidelines (e.g., ACC/AHA). Mechanism is precise and board-relevant. Minimal fix: none required, as item is unambiguous and accurate; optionally, explicitly state LV hypertrophy in stem for added clarity without changing intent.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-008", "question": "A 4-week-old male infant is admitted with a 2-day history of poor feeding, lethargy, and vomiting. He was born at term, breastfeeding well until this illness. Vital signs: T 36.8°C, HR 180 bpm, RR 65/min, BP 65/40 mmHg, SpO2 98% room air. He is mottled, with delayed capillary refill. Laboratory studies show: Na 125 mEq/L, K 8.9 mEq/L, Cl 94 mEq/L, CO2 14 mEq/L, glucose 48 mg/dL, Ca 9.8 mg/dL. Point-of-care cortisol is 2 mcg/dL (drawn prior to any steroid administration). Which of the following is the most urgent diagnostic test to confirm the underlying etiology?", "options": ["Plasma renin activity and aldosterone level", "Karyotype analysis", "Serum 17-hydroxyprogesterone level", "ACTH stimulation test", "Urine organic acid analysis"], "answer": "C", "answer_index": 2, "explanation": "The infant presents in acute adrenal crisis with profound hyponatremia, hyperkalemia, hypoglycemia, and low cortisol, diagnostic of primary adrenal insufficiency. The most common cause in a male infant is congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is detected by a markedly elevated serum 17-hydroxyprogesterone level. This is the most urgent specific diagnostic test, as it guides definitive management and genetic counseling. Plasma renin activity will be elevated, but does not specify the etiology. Karyotype is not urgent; males with CAH have a 46,XY karyotype. An ACTH stimulation test is diagnostic for adrenal insufficiency but is contraindicated in acute crisis and does not identify the specific enzyme defect. Urine organic acids help diagnose other metabolic disorders.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 4-week-old male infant with acute adrenal crisis (poor feeding, lethargy, vomiting, tachycardia, hypotension, mottling, delayed refill); labs show hyponatremia (125 mEq/L), hyperkalemia (8.9 mEq/L), hypoglycemia (48 mg/dL), low cortisol (2 mcg/dL), driving suspicion for primary adrenal insufficiency, most likely congenital adrenal hyperplasia (CAH) in this age/sex. The question asks for the most urgent diagnostic test to confirm etiology. C (serum 17-hydroxyprogesterone) fits as it specifically detects 21-hydroxylase deficiency, the common CAH cause, guiding management. Alternatives: A (renin/aldosterone) supports mineralocorticoid deficiency but not etiology-specific; B (karyotype) irrelevant for classic CAH in phenotypic male; D (ACTH stimulation) contraindicated in acute crisis and non-specific for enzyme defect; E (urine organic acids) for other inborn errors, not adrenal-focused. No main logical issues; stem allows unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with guidelines (e.g., Endocrine Society) for CAH screening via 17-OHP in suspected cases, though newborn screening is standard but not mentioned here. Minimal fix: None needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 4-week-old male infant with acute adrenal crisis (poor feeding, lethargy, vomiting, tachycardia, hypotension, mottling, delayed refill); labs show hyponatremia (125 mEq/L), hyperkalemia (8.9 mEq/L), hypoglycemia (48 mg/dL), low cortisol (2 mcg/dL), driving suspicion for primary adrenal insufficiency, most likely congenital adrenal hyperplasia (CAH) in this age/sex. The question asks for the most urgent diagnostic test to confirm etiology. C (serum 17-hydroxyprogesterone) fits as it specifically detects 21-hydroxylase deficiency, the common CAH cause, guiding management. Alternatives: A (renin/aldosterone) supports mineralocorticoid deficiency but not etiology-specific; B (karyotype) irrelevant for classic CAH in phenotypic male; D (ACTH stimulation) contraindicated in acute crisis and non-specific for enzyme defect; E (urine organic acids) for other inborn errors, not adrenal-focused. No main logical issues; stem allows unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with guidelines (e.g., Endocrine Society) for CAH screening via 17-OHP in suspected cases, though newborn screening is standard but not mentioned here. Minimal fix: None needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-009", "question": "A 32-year-old woman with a history of systemic sclerosis (limited cutaneous variant, anti-centromere positive) presents to the rheumatology clinic for routine follow-up. She reports excellent control of her Raynaud's phenomenon and stable skin disease. She has no cardiac or renal symptoms. Her vital signs are normal. A screening transthoracic echocardiogram is performed, which reveals normal left and right ventricular size and function, but there is a small to moderate pericardial effusion. Which of the following findings on echocardiogram would be the strongest indicator to initiate specific pharmacologic therapy directed at the effusion?", "options": ["Right atrial diastolic collapse", "Respiratory variation in mitral inflow velocity >25%", "Inferior vena cava plethora with <50% collapse on sniff", "Swinging heart motion", "Left atrial compression during systole"], "answer": "C", "answer_index": 2, "explanation": "In a patient with a chronic, stable effusion (like those common in connective tissue diseases), the strongest echocardiographic sign of hemodynamic compromise (tamponade physiology) is inferior vena cava (IVC) plethora with minimal respiratory collapse (<50%). This indicates elevated right atrial pressure. In chronic effusions, the chambers have had time to adapt, so classic signs like right atrial collapse may be absent or late. Respiratory variation in mitral inflow (>25%) is a sensitive sign but can be seen in other conditions like COPD. Right atrial collapse is an early sign but less specific in chronic settings. Swinging heart is seen with very large effusions but not specific for tamponade. Left atrial compression is rare.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include the patient's history of systemic sclerosis with a small to moderate pericardial effusion on screening echocardiogram, normal ventricular function, and absence of symptoms, implying a chronic, stable effusion where therapy is indicated only for hemodynamic compromise like tamponade physiology. The question asks for the strongest echocardiographic indicator to initiate specific pharmacologic therapy for the effusion, focusing on signs of elevated right atrial pressure in this context. Option C (IVC plethora with <50% collapse) is defensible as the most specific for tamponade in chronic effusions, where chambers adapt and classic signs may be absent. Alternatives are weaker: A (right atrial collapse) is early but less specific chronically; B (mitral inflow variation >25%) is sensitive but nonspecific (e.g., in COPD); D (swinging heart) indicates large effusions but not necessarily tamponade; E (left atrial compression) is rare and not standard. No main logical issues; the stem is sufficient, consistent, and discriminates a unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with current guidelines on pericardial effusion management, emphasizing IVC assessment for tamponade in connective tissue diseases. Minimal fix: None needed; item is unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include the patient's history of systemic sclerosis with a small to moderate pericardial effusion on screening echocardiogram, normal ventricular function, and absence of symptoms, implying a chronic, stable effusion where therapy is indicated only for hemodynamic compromise like tamponade physiology. The question asks for the strongest echocardiographic indicator to initiate specific pharmacologic therapy for the effusion, focusing on signs of elevated right atrial pressure in this context. Option C (IVC plethora with <50% collapse) is defensible as the most specific for tamponade in chronic effusions, where chambers adapt and classic signs may be absent. Alternatives are weaker: A (right atrial collapse) is early but less specific chronically; B (mitral inflow variation >25%) is sensitive but nonspecific (e.g., in COPD); D (swinging heart) indicates large effusions but not necessarily tamponade; E (left atrial compression) is rare and not standard. No main logical issues; the stem is sufficient, consistent, and discriminates a unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with current guidelines on pericardial effusion management, emphasizing IVC assessment for tamponade in connective tissue diseases. Minimal fix: None needed; item is unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-010", "question": "A 16-year-old girl is brought to the ED after collapsing during her high school soccer game. She was pulseless and apneic but received immediate bystander CPR and was defibrillated once with ROSC after 4 minutes. Her initial ECG in the ED shows sinus rhythm with diffuse ST-segment elevation in precordial leads V1-V4 and inferior leads II, III, aVF. Bedside echocardiogram shows severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. Troponin I is elevated at 15 ng/mL. Which of the following is the most critical next step in management to prevent recurrence?", "options": ["Immediate coronary angiography", "Initiation of an intravenous beta-blocker", "Insertion of a wearable cardioverter-defibrillator", "Initiation of intravenous immunoglobulin (IVIG)", "Administration of intravenous calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation and echocardiographic findings are classic for Takotsubo (stress) cardiomyopathy, which can rarely present with ventricular fibrillation arrest. The ECG can mimic STEMI. The most critical step to prevent recurrence of malignant arrhythmias in the acute phase is suppression of catecholamine-driven triggered activity with an intravenous beta-blocker. Immediate coronary angiography is often performed to rule out acute coronary syndrome, but the typical regional wall motion abnormality (apical ballooning) and clinical context make it less likely to be the immediate preventive measure for recurrence. ICD implantation is not indicated in the acute phase of a reversible cardiomyopathy. IVIG is for myocarditis. Calcium is for hyperkalemia or calcium channel blocker overdose.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. The clinical problem is identifying the most critical next step to prevent recurrence of cardiac arrest in a 16-year-old girl with post-arrest ST-segment elevation and echocardiographic findings suggestive of Takotsubo cardiomyopathy. Key stem clues: sudden collapse during high-stress activity (soccer), pulseless/apneic with VF defibrillated to ROSC, ECG showing diffuse ST elevation in V1-V4 and inferior leads, echo with mid-apical LV hypokinesis and basal hypercontractility, elevated troponin at 15 ng/mL. These imply Takotsubo but require excluding ACS for diagnosis. Keyed answer B (IV beta-blocker) fits catecholamine suppression to prevent arrhythmic recurrence assuming Takotsubo, but assumes unconfirmed diagnosis and ignores potential hemodynamic risks in hypokinetic state. Alternatives: A (immediate coronary angiography) is superior as guidelines mandate it for post-arrest STEMI to rule out ACS/coronary anomalies, directly preventing recurrence if ischemic cause; C unsuitable for acute reversible cardiomyopathy; D for myocarditis, not matching echo; E irrelevant without electrolyte issues. Main logical issue: Unique best answer exists (A), but key is B, fitting miskeyed definition. Main medical accuracy issues: Contradicts AHA guidelines for emergent angiography in post-arrest ST elevation; Takotsubo is diagnosis of exclusion, rare in adolescents; beta-blockers not first-line without confirming non-ischemic etiology, potentially harmful in cardiogenic shock. Minimal fix: Change the keyed answer to A.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. The clinical problem is identifying the most critical next step to prevent recurrence of cardiac arrest in a 16-year-old girl with post-arrest ST-segment elevation and echocardiographic findings suggestive of Takotsubo cardiomyopathy. Key stem clues: sudden collapse during high-stress activity (soccer), pulseless/apneic with VF defibrillated to ROSC, ECG showing diffuse ST elevation in V1-V4 and inferior leads, echo with mid-apical LV hypokinesis and basal hypercontractility, elevated troponin at 15 ng/mL. These imply Takotsubo but require excluding ACS for diagnosis. Keyed answer B (IV beta-blocker) fits catecholamine suppression to prevent arrhythmic recurrence assuming Takotsubo, but assumes unconfirmed diagnosis and ignores potential hemodynamic risks in hypokinetic state. Alternatives: A (immediate coronary angiography) is superior as guidelines mandate it for post-arrest STEMI to rule out ACS/coronary anomalies, directly preventing recurrence if ischemic cause; C unsuitable for acute reversible cardiomyopathy; D for myocarditis, not matching echo; E irrelevant without electrolyte issues. Main logical issue: Unique best answer exists (A), but key is B, fitting miskeyed definition. Main medical accuracy issues: Contradicts AHA guidelines for emergent angiography in post-arrest ST elevation; Takotsubo is diagnosis of exclusion, rare in adolescents; beta-blockers not first-line without confirming non-ischemic etiology, potentially harmful in cardiogenic shock. Minimal fix: Change the keyed answer to A.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}]